Predicting memory decline in normal elderly: Genetics, MRI, and cognitive reserve

Neurobiology of Aging

Volumn 28, Issue 11, 2007, Pages 1644-1656

  Tupler, Larry A ^a   Krishnan, K Ranga R ^a   Greenberg, Daniel L ^a   Marcovina, Santica M ^b   Payne, Martha E ^a   MacFall, James R ^a   Charles, H Cecil ^a   Doraiswamy, P Murali ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; California Verbal Learning Test; Cerebral volume; Hippocampus; Memory; Morphometry; MRI; Normal aging

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; COGNITION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MULTIPLE REGRESSION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECALL; SEX RATIO; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS;

EID: 34548543513     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.07.001     Document Type: Article

References (104)

1. Barnes J., Scahill R.I., Schott J.M., Frost C., Rossor M.N., and Fox N.C. Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dement Geriatr Cogn Disord 19 5-6 (2005) 338-344
2. Baxter L.C., Caselli R.J., Johnson S.C., Reiman E., and Osborne D. Apolipoprotein E ε4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiol Aging 24 7 (2003) 947-952
3. Bigler E.D., Lowry C.M., Anderson C.V., Johnson S.C., Terry J., and Steed M. Dementia, quantitative neuroimaging, and apolipoprotein E genotype. AJNR Am J Neuroradiol 21 10 (2000) 1857-1868
4. Bigler E.D., Lowry C.M., Kerr B., Tate D.F., Hessel C.D., Earl H.D., et al. Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging. Neuropsychology 17 3 (2003) 339-352
5. Bigler E.D., Tate D.F., Miller M.J., Rice S.A., Hessel C.D., Earl H.D., et al. Dementia, asymmetry of temporal lobe structures, and apolipoprotein E genotype: relationships to cerebral atrophy and neuropsychological impairment. J Int Neuropsychol Soc 8 7 (2002) 925-933
6. Blair C.K., Folsom A.R., Knopman D.S., Bray M.S., Mosley T.H., and Boerwinkle E. APOE genotype and cognitive decline in a middle-aged cohort. Neurology 64 2 (2005) 268-276
7. Bondi M.W., Houston W.S., Salmon D.P., Corey-Bloom J., Katzman R., Thal L.J., et al. Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores. J Int Neuropsychol Soc 9 5 (2003) 783-795
8. Bondi M.W., Salmon D.P., Galasko D., Thomas R.G., and Thal L.J. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging 14 2 (1999) 295-303
9. Bondi M.W., Salmon D.P., Monsch A.U., Galasko D., Butters N., Klauber M.R., et al. Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults. Neurology 45 12 (1995) 2203-2206
10. Borenstein A.R., Wu Y., Mortimer J.A., Schellenberg G.D., McCormick W.C., Bowen J.D., et al. Developmental and vascular risk factors for Alzheimer's disease. Neurobiol Aging 26 3 (2005) 325-334
11. Bunce D., Fratiglioni L., Small B.J., Winblad B., and Bäckman L. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology 63 5 (2004) 816-821
12. Byrum C.E., MacFall J.R., Charles H.C., Chitilla V.R., Boyko O.B., Upchurch L., et al. Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method. Psychiatry Res 67 3 (1996) 215-234
13. Caselli R.J., Osborne D., Reiman E.M., Hentz J.G., Barbieri C.J., Saunders A.M., et al. Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study. J Neurol Sci 189 1-2 (2001) 93-98
14. Chen J.G., Edwards C.L., Vidyarthi S., Pitchumoni S., Tabrizi S., Barboriak D., et al. Learning and recall in subjects at genetic risk for Alzheimer's disease. J Neuropsychiatry Clin Neurosci 14 1 (2002) 58-63
15. Cohen R.M., Small C., Lalonde F., Friz J., and Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 57 12 (2001) 2223-2228
16. Convit A., de Asis J., de Leon M.J., Tarshish C.Y., De Santi S., and Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 21 1 (2000) 19-26
17. Convit A., de Leon M.J., Tarshish C., De Santi S., Tsui W., Rusinek H., et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 18 2 (1997) 131-138
18. Dal Forno G., Rasmusson D.X., Brandt J., Carson K.A., Brookmeyer R., Troncoso J., et al. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 53 4 (1996) 345-350
19. de Toledo-Morrell L., Dickerson B., Sullivan M.P., Spanovic C., Wilson R., and Bennett D.A. Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus 10 2 (2000) 136-142
20. Deary I.J., Whiteman M.C., Pattie A., Starr J.M., Hayward C., Wright A.F., et al. Cognitive change and the APOE ε4 allele. Nature 418 6901 (2002) 932
21. den Heijer T., Oudkerk M., Launer L.J., van Duijn C.M., Hofman A., and Breteler M.M.B. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 59 5 (2002) 746-748
22. Dik M.G., Jonker C., Bouter L.M., Geerlings M.I., van Kamp G.J., and Deeg D.J.H. APOE-ε4 is associated with memory decline in cognitively impaired elderly. Neurology 54 7 (2000) 1492-1497
23. Dik M.G., Jonker C., Comijs H.C., Bouter L.M., Twisk J.W.R., van Kamp G.J., et al. Memory complaints and APOE-ε4 accelerate cognitive decline in cognitively normal elderly. Neurology 57 12 (2001) 2217-2222
24. Duvernoy H.M. The human hippocampus. 2nd ed. (1998), Springer, New York
25. Estévez-González A., García-Sánchez C., Boltes A., Otermín P., Baiget M., Escartín A., et al. Preclinical memory profile in Alzheimer patients with and without allele APOE-epsilon4. Eur Neurol 51 4 (2004) 199-205
26. Finton M.J., Lucas J.A., Rippeth J.D., Bohac D.L., Smith G.E., Ivnik R.J., et al. Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease. J Int Neuropsychol Soc 9 5 (2003) 751-759
27. Flory J.D., Manuck S.B., Ferrell R.E., Ryan C.M., and Muldoon M.F. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am J Med Genet 96 6 (2000) 707-711
28. Foster J.K., Meikle A., Goodson G., Mayes A.R., Howard M., Sünram S.I., et al. The hippocampus and delayed recall: bigger is not necessarily better?. Memory 7 5-6 (1999) 715-732
29. Geroldi C., Laakso M.P., DeCarli C., Beltramello A., Bianchetti A., Soininen H., et al. Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry 68 1 (2000) 93-96
30. Geroldi C., Pihlajamäki M., Laakso M.P., DeCarli C., Beltramello A., Bianchetti A., et al. APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 53 8 (1999) 1825-1832
31. Golomb J., de Leon M.J., Kluger A., George A.E., Tarshish C., and Ferris S.H. Hippocampal atrophy in normal aging. An association with recent memory impairment. Arch Neurol 50 9 (1993) 967-973
32. Greenwood P.M., Lambert C., Sunderland T., and Parasuraman R. Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results from the National Institute of Mental Health's BIOCARD study. Neuropsychology 19 2 (2005) 199-211
33. Grundman M., Sencakova D., Jack Jr. C.R., Petersen R.C., Kim H.T., Schultz A., et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci 19 1-2 (2002) 23-27
34. Hackert V.H., den Heijer T., Oudkerk M., Koudstaal P.J., Hofman A., and Breteler M.M.B. Hippocampal head size associated with verbal memory performance in nondemented elderly. Neuroimage 17 3 (2002) 1365-1372
35. Hashimoto M., Yasuda M., Tanimukai S., Matsui M., Hirono N., Kazui H., et al. Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 57 8 (2001) 1461-1466
36. Hirono N., Hashimoto M., Yasuda M., Kazui H., and Mori E. Accelerated memory decline in Alzheimer's disease with apolipoprotein ε4 allele. J Neuropsychiatry Clin Neurosci 15 3 (2003) 354-358
37. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 3 (1990) 545-548
38. Hofer S.M., Christensen H., Mackinnon A.J., Korten A.E., Jorm A.F., Henderson A.S., et al. Change in cognitive functioning associated with apoE genotype in a community sample of older adults. Psychol Aging 17 2 (2002) 194-208
39. Howieson D.B., Camicioli R., Quinn J., Silbert L.C., Care B., Moore M.M., et al. Natural history of cognitive decline in the old old. Neurology 60 9 (2003) 1489-1494
40. Hsiung G.-Y.R., Sadovnick A.D., and Feldman H. Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ 171 8 (2004) 863-867
41. Jack Jr. C.R., Petersen R.C., Xu Y.C., O'Brien P.C., Smith G.E., Ivnik R.J., et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52 7 (1999) 1397-1403
42. Jani J., Prettyman R., Aslam M., Trantor J., and Cherryman G. A retrospective study of neuroradiological abnormalities detected on structural magnetic resonance imaging of the brain in elderly patients with cognitive impairment. Int J Geriatr Psychiatry 15 11 (2000) 1054-1060
43. Järvenpää T., Laakso M.P., Rossi R., Koskenvuo M., Kaprio J., Räihä I., et al. Hippocampal MRI volumetry in cognitively discordant monozygotic twin pairs. J Neurol Neurosurg Psychiatry 75 1 (2004) 116-120
44. Kang J.H., Logroscino G., De Vivo I., Hunter D., and Grodstein F. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging 26 4 (2005) 475-484
45. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J Int Neuropsychol Soc 8 7 (2002) 934-942
46. Kikinis R., Shenton M.E., Gerig G., Martin J., Anderson M., Metcalf D., et al. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging 2 6 (1992) 619-629
47. Klages J.D., Fisk J.D., and Rockwood K. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 15 1 (2003) 1-5
48. Köhler S., Black S.E., Sinden M., Szekely C., Kidron D., Parker J.L., et al. Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer's disease. Neuropsychologia 36 9 (1998) 901-914
49. Kramer J.H., Schuff N., Reed B.R., Mungas D., Du A.-T., Rosen H.J., et al. Hippocampal volume and retention in Alzheimer's disease. J Int Neuropsychol Soc 10 4 (2004) 639-643
50. Laakso M.P., Lehtovirta M., Partanen K., Riekkinen Sr. P.J., and Soininen H. Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study. Biol Psychiatry 47 6 (2000) 557-561
51. Laakso M.P., Soininen H., Partanen K., Lehtovirta M., Hallikainen M., Hänninen T., et al. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 19 1 (1998) 23-31
52. Lange K.L., Bondi M.W., Salmon D.P., Galasko D., Delis D.C., Thomas R.G., et al. Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype. J Int Neuropsychol Soc 8 7 (2002) 943-955
53. Lasser R.A., Dukoff R., Levy J., Levin R., Lehtimäki T., Seubert P., et al. Apolipoprotein E ε4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease. Int J Geriatr Psychiatry 13 11 (1998) 767-774
54. Lehtovirta M., Laakso M.P., Soininen H., Helisalmi S., Mannermaa A., Helkala E.-L., et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 67 1 (1995) 65-72
55. 4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 24 4 (2005) 1205-1213
56. Levy J.A., Bergeson J., Putnam K., Rosen V., Cohen R., Lalonde F., et al. Context-specific memory and apolipoprotein E (ApoE) ε4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease. J Int Neuropsychol Soc 10 3 (2004) 362-370
57. Lezak M.D. Neuropsychological assessment. 3rd ed. (1995), Oxford University Press, New York
58. Lye T.C., Piguet O., Grayson D.A., Creasey H., Ridley L.J., Bennett H.P., et al. Hippocampal size and memory function in the ninth and tenth decades of life: the Sydney Older Persons Study. J Neurol Neurosurg Psychiatry 75 4 (2004) 548-554
59. Marquis S., Moore M.M., Howieson D.B., Sexton G., Payami H., Kaye J.A., et al. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 59 4 (2002) 601-606
60. Mayeux R., Saunders A.M., Shea S., Mirra S., Evans D., Roses A.D., et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N Engl J Med 338 8 (1998) 506-511
61. Mayeux R., Small S.A., Tang M.-X., Tycko B., and Stern Y. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. Neurobiol Aging 22 4 (2001) 683-689
62. Mega M.S., Small G.W., Xu M.L., Felix J., Manese M., Tran N.P., et al. Hippocampal atrophy in persons with age-associated memory impairment: volumetry within a common space. Psychosom Med 64 3 (2002) 487-492
63. Moffat S.D., Szekely C.A., Zonderman A.B., Kabani N.J., and Resnick S.M. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 55 1 (2000) 134-136
64. Mortensen E.L., and Høgh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 57 1 (2001) 89-95
65. Mueller E.A., Moore M.M., Kerr D.C.R., Sexton G., Camicioli R.M., Howieson D.B., et al. Brain volume preserved in healthy elderly through the eleventh decade. Neurology 51 6 (1998) 1555-1562
66. Nacmias B., Piccini C., Bagnoli S., Tedde A., Cellini E., Bracco L., et al. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci Lett 367 3 (2004) 379-383
67. Nilsson L.-G., Nyberg L., and Bäckman L. Genetic variation in memory functioning. Neurosci Biobehav Rev 26 7 (2002) 841-848
68. Pantel J., Schönknecht P., Essig M., and Schröder J. Distribution of cerebral atrophy assessed by magnetic resonance imaging reflects patterns of neuropsychological deficits in Alzheimer's dementia. Neurosci Lett 361 1-3 (2004) 17-20
69. Paolo A.M., Tröster A.I., and Ryan J.J. Test-retest stability of the California Verbal Learning Test in older persons. Neuropsychology 11 4 (1997) 613-616
70. Payne M.E., Fetzer D.L., MacFall J.R., Provenzale J.M., Byrum C.E., and Krishnan K.R.R. Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res 115 1-2 (2002) 63-77
71. Pedraza O., Bowers D., and Gilmore R. Asymmetry of the hippocampus and amygdala in MRI volumetric measurements of normal adults. J Int Neuropsychol Soc 10 5 (2004) 664-678
72. Pendleton N., Payton A., van den Boogerd E.H., Holland F., Diggle P., Rabbitt P.M.A., et al. Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults. Neurosci Lett 324 1 (2002) 74-76
73. Plassman B.L., Welsh-Bohmer K.A., Bigler E.D., Johnson S.C., Anderson C.V., Helms M.J., et al. Apolipoprotein E ε4 allele and hippocampal volume in twins with normal cognition. Neurology 48 4 (1997) 985-989
74. Pruessner J.C., Collins D.L., Pruessner M., and Evans A.C. Age and gender predict volume decline in the anterior and posterior hippocampus in early adulthood. J Neurosci 21 1 (2001) 194-200
75. Pruessner J.C., Li L.M., Serles W., Pruessner M., Collins D.L., Kabani N., et al. Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb Cortex 10 4 (2000) 433-442
76. Pucci E., Belardinelli N., Regnicolo L., Nolfe G., Signorino M., Salvolini U., et al. Hippocampus and parahippocampal gyrus linear measurements based on magnetic resonance in Alzheimer's disease. Eur Neurol 39 1 (1998) 16-25
77. Reiman E.M., Uecker A., Caselli R.J., Lewis S., Bandy D., de Leon M.J., et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 44 2 (1998) 288-291
78. Rice F., Abraham R., Rudrasingham V., Owen M.J., and Williams J. Memory for new information as a cognitive marker of liability to Alzheimer's disease in a high risk group: a research note. Int J Geriatr Psychiatry 18 2 (2003) 155-160
79. Riley K.P., Snowdon D.A., Saunders A.M., Roses A.D., Mortimer J.A., and Nanayakkara N. Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study. J Gerontol 55B 2 (2000) S69-S75
80. Romero L.J., Schuyler M., Kamboh M.I., Qualls C., LaRue A., Liang H.C., et al. The APO E4 allele and cognition in New Mexico Hispanic elderly. Ethn Dis 12 2 (2002) 235-241
81. Rosen V.M., Bergeson J.L., Putnam K., Harwell A., and Sunderland T. Working memory and apolipoprotein E: what's the connection?. Neuropsychologia 40 13 (2002) 2226-2233
82. Rosen V.M., Sunderland T., Levy J., Harwell A., McGee L., Hammond C., et al. Apolipoprotein E and category fluency: evidence for reduced semantic access in healthy normal controls at risk for developing Alzheimer's disease. Neuropsychologia 43 4 (2005) 647-658
83. Salat D.H., Kaye J.A., and Janowsky J.S. Greater orbital prefrontal volume selectively predicts worse working memory performance in older adults. Cereb Cortex 12 5 (2002) 494-505
84. Schmidt H., Schmidt R., Fazekas F., Semmler J., Kapeller P., Reinhart B., et al. Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet 50 5 (1996) 293-299
85. Schuff N., Amend D., Ezekiel F., Steinman S.K., Tanabe J., Norman D., et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease: a proton MR spectroscopic imaging and MRI study. Neurology 49 6 (1997) 1513-1521
86. Schuff N., Amend D.L., Knowlton R., Norman D., Fein G., and Weiner M.W. Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol Aging 20 3 (1999) 279-285
87. Serra-Grabulosa J.M., Salgado-Pineda P., Junqué C., Solé-Padullés C., Moral P., López-Alomar A., et al. Apolipoproteins E and C1 and brain morphology in memory impaired elders. Neurogenetics 4 3 (2003) 141-146
88. Shadlen M.-F., Larson E.B., Wang L., Phelan E.A., McCormick W.C., Jolley L., et al. Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline. Neurobiol Aging 26 1 (2005) 17-24
89. Small B.J., Basun H., and Bäckman L. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia. Psychol Aging 13 1 (1998) 80-87
90. Soininen H., Partanen K., Pitkänen A., Hallikainen M., Hänninen T., Helisalmi S., et al. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ε4 allele. Neurology 45 2 (1995) 391-392
91. Soininen H.S., Partanen K., Pitkänen A., Vainio P., Hänninen T., Hallikainen M., et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 44 9 (1994) 1660-1668
92. Staehelin H.B., Perrig-Chiello P., Mitrache C., Miserez A.R., and Perrig W.J. Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol Scand 100 1 (1999) 53-60
93. Sullivan E.V., Marsh L., and Pfefferbaum A. Preservation of hippocampal volume throughout adulthood in healthy men and women. Neurobiol Aging 26 7 (2005) 1093-1098
94. Tierney M.C., Szalai J.P., Snow W.G., Fisher R.H., Nores A., Nadon G., et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 46 3 (1996) 661-665
95. Tisserand D.J., Visser P.J., van Boxtel M.P.J., and Jolles J. The relation between global and limbic brain volumes on MRI and cognitive performance in healthy individuals across the age range. Neurobiol Aging 21 4 (2000) 569-576
96. Tohgi H., Takahashi S., Kato E., Homma A., Niina R., Sasaki K., et al. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E ε4 allele. Neurosci Lett 236 1 (1997) 21-24
97. Tsuang D., Larson E.B., Bowen J., McCormick W., Teri L., Nochlin D., et al. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series. Arch Neurol 56 12 (1999) 1489-1495
98. Tupler L.A., and De Bellis M.D. Segmented hippocampal volume in children and adolescents with posttraumatic stress disorder. Biol Psychiatry 59 6 (2006) 523-529
99. Van Petten C., Plante E., Davidson P.S.R., Kuo T.Y., Bajuscak L., and Glisky E.L. Memory and executive function in older adults: relationships with temporal and prefrontal gray matter volumes and white matter hyperintensities. Neuropsychologia 42 10 (2004) 1313-1335
100. Welsh K.A., Butters N., Hughes J.P., Mohs R.C., and Heyman A. Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 49 5 (1992) 448-452
101. Winnock M., Letenneur L., Jacqmin-Gadda H., Dallongeville J., Amouyel P., and Dartigues J.F. Longitudinal analysis of the effect of apolipoprotein E ε4 and education on cognitive performance in elderly subjects: the PAQUID study. J Neurol Neurosurg Psychiatry 72 6 (2002) 794-797
102. Wolf H., Grunwald M., Kruggel F., Riedel-Heller S.G., Angerhöfer S., Hojjatoleslami A., et al. Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging 22 2 (2001) 177-186
103. Yasuda M., Mori E., Kitagaki H., Yamashita H., Hirono N., Shimada K., et al. Apolipoprotein E ε4 allele and whole brain atrophy in late-onset Alzheimer's disease. Am J Psychiatry 155 6 (1998) 779-784
104. Ylikoski R., Salonen O., Mäntylä R., Ylikoski A., Keskivaara P., Leskelä M., et al. Hippocampal and temporal lobe atrophy and age-related decline in memory. Acta Neurol Scand 101 4 (2000) 273-278